Avicanna (TSX:AVCN) Other Current Receivables : C$-0.02 Mil (As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Avicanna Other Current Receivables?

Avicanna's Other Current Receivables for the quarter that ended in Mar. 2025 was C$-0.02 Mil.

Avicanna's quarterly Other Current Receivables increased from Sep. 2024 (C$-0.84 Mil) to Dec. 2024 (C$-0.20 Mil) and increased from Dec. 2024 (C$-0.20 Mil) to Mar. 2025 (C$-0.02 Mil).

Avicanna's annual Other Current Receivables increased from Dec. 2022 (C$0.03 Mil) to Dec. 2023 (C$0.03 Mil) but then declined from Dec. 2023 (C$0.03 Mil) to Dec. 2024 (C$-0.20 Mil).

Avicanna Other Current Receivables Historical Data

The historical data trend for Avicanna's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avicanna Other Current Receivables Chart

Avicanna Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Current Receivables

Get a 7-Day Free Trial

0.30

1.21

0.03

-0.20

Avicanna Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Current Receivables	Get a 7-Day Free Trial															-	-0.62	-0.84	-0.20	-0.02

Avicanna Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

Avicanna Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Avicanna's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Avicanna Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Avicanna Inc (TSX:AVCN) » Definitions » Other Current Receivables

Comparable Companies

Traded in Other Exchanges

AVCNF:USA 0NN:Germany

Address

480 University Avenue, Suite 1502, Toronto, BC, CAN, M5G 1V2

Website

https://www.avicanna.com

Avicanna Inc is a commercial-stage international biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for the global medical and pharmaceutical market segments. It has three operating segments: Canada, International, and Corporate. It generates the majority of its revenue from Canada.

Executives

Sheldon Inwentash	10% Security Holder
Threed Capital Inc.	10% Security Holder
Phillip Cardella	Senior Officer
Phillip Stanley Cardella	Senior Officer
Aras Azadian	Director, Senior Officer
Davender Sohi	Senior Officer
David White	Director
Kyle Lawrence Langstaff	Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Chandra Panchal	Director
Janet Giesselman	Director

Avicanna Headlines

No Headlines